IM Cannabis Announces Intention to Complete 3:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
IM Cannabis (IMCC) approved a 1-for-3 reverse share split that the company expects to take effect on November 23, 2026. Split-adjusted trading is expected to begin at the Nasdaq Capital Market open that day, subject to final Nasdaq confirmation and completion of implementation steps. Outstanding common shares are expected to fall from 1,844,162 to approximately 614,721, subject to rounding.
The company said the split is intended to raise the per-share trading price to help maintain compliance with Nasdaq's US$1.00 minimum bid price. Because IM Cannabis completed a 30-for-1 share consolidation on August 27, 2026, it would not qualify for the usual 180-calendar-day compliance period if its closing bid stayed below US$1.00 for 30 consecutive business days. Nasdaq staff would then issue a delisting determination.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq delisting determination would follow 30 consecutive business days with a closing bid below US$1.00, without the usual 180-calendar-day compliance period.
- Minor point. Forward-looking: it has not happened yet and may not happen.1-for-3 reverse split to support Nasdaq compliance is expected November 23, 2026, reducing outstanding common shares from 1,844,162 to approximately 614,721, subject to rounding.
- Minor pointSplit-adjusted trading still requires final Nasdaq confirmation and completion of corporate, transfer agent and market implementation steps.
News Explained
Outstanding convertible, exchangeable and exercisable securities will have their share counts and exercise or conversion prices adjusted if the consolidation takes effect.
The board has approved a consolidation of three existing shares into one, currently expected to take effect on
If completed, the share counts and exercise or conversion prices for outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted under their terms.
Details
Market move: IMCC +6.26% vs previous close. 3:1 share consolidation
On Nov 18, the day this news came out, the latest delayed price for IMCC is 6.26% above the previous close. Argus tracked a peak move of +1.7% during the session. Our momentum scanner has recorded 6 alerts for this stock so far that day. The latest delayed price is $0.52. Relative volume is very high at 3.3x what this stock usually trades by this time of day.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Consolidation ratio
- 1 post-consolidated share for every 3 pre-consolidated shares
- Board-approved 3:1 share consolidation
- Expected effective date
- November 23, 2026
- Subject to completion of applicable processes
- Expected shares outstanding
- From 1,844,162 to approximately 614,721 shares
- After consolidation; subject to fractional-share rounding
- Nasdaq minimum bid requirement
- US$1.00 per share
- Continued-listing requirement
- Prior share consolidation
- 30:1
- Effected August 27, 2026
- Bid-price deficiency threshold
- Below US$1.00 for 30 consecutive business days
- Would make the company ineligible for a compliance period and trigger a Staff Delisting Determination
- Ordinary compliance period
- 180 calendar days
- Not available to a company that effected a reverse share split during the prior one-year period
- Prior daily close
- $0.4937
- November 17, before this announcement
Historical Context
-
Nasdaq confirmed compliance after the closing bid stayed at least $1.00 for 18 consecutive business days.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
cusip financial
isin financial
staff delisting determination regulatory
direct registration system financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Board has authorized the Consolidation to be effected, with the Company currently expecting November 23, 2026 to be the effective date of the Consolidation (the "Effective Date"). The Company anticipates that the Common Shares will begin trading on the Nasdaq Capital Market ("Nasdaq") on a post-Consolidation basis at the opening of trading on November 23, 2026, subject to final confirmation from Nasdaq and completion of applicable corporate, transfer agent and market implementation processes.
Upon the completion of the Consolidation, the CUSIP and ISIN of the Common Shares will be changed to 44969Q604 and CA44969Q6040, respectively. The Company's name and existing stock symbol "IMCC" will remain unchanged.
After giving effect to the Consolidation, the issued and outstanding Common Shares are expected to be reduced from 1,844,162 Common Shares to approximately 614,721 Common Shares, subject to rounding for fractional Common Shares. No fractional Common Shares will be issued in connection with the Consolidation. Instead, all fractional Common Shares equal to or greater than one-half resulting from the Consolidation will be rounded to the next whole number, otherwise, the fractional Common Share will be cancelled. The exercise price and/or conversion price and the number of Common Shares issuable under the Company's outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted in connection with the Consolidation in accordance with their respective terms.
The primary purpose of the Consolidation is to increase the per-share trading price of the Common Shares in an effort to support the Company's efforts to maintain compliance with Nasdaq's
Registered shareholders as of the Effective Date will receive a letter of transmittal from Computershare Investor Services Inc., the Company's registrar and transfer agent for its Common Shares, providing instructions for the exchange of their Common Shares as soon as practicable following the Effective Date. Registered shareholders may also obtain a copy of the letter of transmittal by accessing the Company's SEDAR+ profile at www.sedarplus.ca. Until surrendered, each share certificate or direct registration system statement representing pre-consolidated Common Shares will represent the number of whole post-consolidated Common Shares to which the holder is entitled as a result of the Consolidation. No action is required by beneficial holders to receive post-consolidation Common Shares in connection with the Consolidation. Beneficial shareholders who hold their Common Shares through intermediaries (e.g., a broker, bank, trust company, investment dealer or other financial institution) and who have questions regarding how the Consolidation will be processed should contact their intermediaries with respect to the Consolidation.
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) is an international company currently operating a medical cannabis platform serving patients in Israel.
The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms in Israel that enable the safe delivery and quality control of IMC products throughout the value chain.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws (collectively, "forward-looking statements"). Forward-looking statements are based on expectations, estimates, projections and interpretations as at the date of this press release and are often, but not always, identified by words and phrases such as "anticipate", "believe", "expect", "intend", "may", "plan", "should", "will", "would", "could", "estimate", "target", "subject to", "scheduled", "currently expects" and similar words or expressions.
Forward-looking statements in this press release include, without limitation, statements regarding the Consolidation, including the expected completion of the Consolidation, the Consolidation ratio, the expected Effective Date, the anticipated date on which the Common Shares will begin trading on a post-Consolidation basis on Nasdaq, the expected change to the CUSIP and ISIN numbers of the Common Shares, the expected number of Common Shares outstanding following completion of the Consolidation, the treatment of fractional Common Shares, proportionate adjustments to the exercise price and/or conversion price and number of Common Shares issuable under outstanding convertible, exchangeable or exercisable securities of the Company, the Company's expectation that the Consolidation will increase the per-share trading price of the Common Shares, the Company's intention and ability to maintain compliance with Nasdaq's US
Forward-looking statements are based on a number of assumptions, including, without limitation, that the Consolidation will be completed on the anticipated terms and timeline; that all required corporate, regulatory, Nasdaq, DTC, transfer agent and other confirmations, approvals, filings, notices or processes will be obtained, made or completed when expected; that the Common Shares will begin trading on a post-Consolidation basis on Nasdaq on the anticipated date; that the Consolidation will result in an increase in the per-share trading price of the Common Shares; that the trading price of the Common Shares will be sufficient for the Company to maintain compliance with Nasdaq's US
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, without limitation: the risk that the Consolidation may not be completed on the anticipated timeline or at all; the risk that required confirmations, approvals, filings, notices or processes may be delayed, withheld, conditional or not completed as expected; the risk that the Common Shares may not begin trading on a post-Consolidation basis on the anticipated date; the risk that the Consolidation may not result in a sustained increase in the per-share trading price of the Common Shares; the risk that the Company may not maintain compliance with Nasdaq's US
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management as of such date. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Michal Efraty
Investor & Public Relations
IM Cannabis Corp.
michal@efraty.com
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/im-cannabis-announces-intention-to-complete-31-share-consolidation-to-support-nasdaq-minimum-bid-price-compliance-302944222.html
SOURCE IM Cannabis Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.